18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT)
- 1 July 1999
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 35 (7) , 1076-1082
- https://doi.org/10.1016/s0959-8049(99)00077-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Unknown primary tumoursCancer Treatment Reviews, 1994
- Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.Radiology, 1993
- Treatment of Patients with Cancer of an Unknown Primary SiteNew England Journal of Medicine, 1993
- Cancer Detection with Whole-Body PET Using 2-[18F]Fluoro-2-Deoxy-D-GlucoseJournal of Computer Assisted Tomography, 1993
- Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose.Radiology, 1991
- High serum thyroglobulin levels: Diagnostic indicators in patients with metastases from unknown primary sitesCancer, 1987
- Computed tomography in the evaluation of metastatic adenocarcinoma from an unknown primary site. A retrospective study.Radiology, 1982
- Identifying the Primary Site in Metastatic Cancer of Unknown OriginPublished by American Medical Association (AMA) ,1979
- On the Origin of Cancer CellsScience, 1956